Patrick Flamen - Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles

基本信息

浏览量：142

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 417 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure S1 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

Mattia Rediti,Danai Fimereli,Magdalena Mileva,Zéna Wimana,David Venet,Patrick Flamen,Thomas Guiot,Elisabeth G.E. de Vries,Carolien P. Schröder, Catharina Willemien Menke-van der Houven van Oordt,Marion Maetens,Samira Majjaj,Denis Larsimont,Françoise Rothé,Christos Sotiriou,Géraldine Gebhart

crossref（2025）

引用0浏览0引用

Supplementary Table S2 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

Supplementary Figure S4 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

[18F]FDG Metabolic Tumor Volume As a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study

David L Chan,Aimee Hayes,Ioannis Karfis, Alice Conner,Magdalena Mileva, Elizabeth Bernard,Shaunak Navalkissoor, Gopinath Gnanasekaran, Stephen J Clarke,Paul J Roach,Patrick Flamen, Martyn E Caplin,Nick Pavlakis,Christos Toumpanakis, Dale L Bailey

Journal of nuclear medicine official publication, Society of Nuclear Medicine (2025)

引用0浏览0WOS引用

Supplementary Table S7 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

Supplementary Figure S3 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

Supplementary Figure S5 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

Supplementary Table S9 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

Supplementary Figure S6 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

Supplementary Figure S2 from Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

crossref（2025）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn